These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11490541)

  • 1. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
    Debove P; Simon F; Vaylet F; Renard JL; L'Her P
    Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffuse interstitial lung disease without pleural involvement and high-dose bromocriptine].
    Marsaudon E; Castet D; Barrault MF; Allais C
    Rev Mal Respir; 1997 Nov; 14(5):405-7. PubMed ID: 9480488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity].
    Douvier JJ; Vergeret J; Taytard A; Brottier E; Domblides P; Dubos F; Freour P
    Ann Med Interne (Paris); 1985; 136(5):416-8. PubMed ID: 4062141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pleural effusion induced by bromocriptine].
    Diot E; Diot P; Le Rolland A; Jonville AP; Lasfargues G; Lemarie E; Lavandier M; Guilmot JL
    Rev Mal Respir; 1990; 7(2):175-7. PubMed ID: 2320790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
    McElvaney NG; Wilcox PG; Churg A; Fleetham JA
    Arch Intern Med; 1988 Oct; 148(10):2231-6. PubMed ID: 3178380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bromocriptine-induced pleuropneumopathy].
    Schmid PA; Suter T; Speich R; Eberli F; Greminger P
    Dtsch Med Wochenschr; 1994 Nov; 119(45):1543-6. PubMed ID: 7956789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.
    Hillerdal G; Lee J; Blomkvist A; Rask-Andersen A; Uddenfeldt M; Koyi H; Rasmussen E
    Eur Respir J; 1997 Dec; 10(12):2711-5. PubMed ID: 9493648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pleuropulmonary fibrosis and bromocriptine].
    Vergeret J; Barat M; Taytard A; Bellvert P; Domblides P; Douvier JJ; Fréour P
    Sem Hop; 1984 Mar; 60(11):741-4. PubMed ID: 6324351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe pleuropericarditis induced by long-term bromocriptin therapy, report of a case and review of the literature].
    Ciubotaru V; Poinsignon Y; Brunet-Bourgin F; Mestassi M; Rosenbaum D
    Rev Med Interne; 2004 Apr; 25(4):310-4. PubMed ID: 15050800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
    Todman DH; Oliver WA; Edwards RL
    Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.
    Tintner R; Manian P; Gauthier P; Jankovic J
    Arch Neurol; 2005 Aug; 62(8):1290-5. PubMed ID: 16087771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
    Knoop C; Mairesse M; Lenclud C; Gevenois PA; De Vuyst P
    Eur Respir J; 1997 Dec; 10(12):2898-901. PubMed ID: 9493681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
    Champagne S; Coste E; Peyrière H; Nigond J; Mania E; Pons M; Hillaire-Buys D; Balmes P; Blayac JP; Davy JM
    Ann Pharmacother; 1999 Oct; 33(10):1050-4. PubMed ID: 10534217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
    Grosset K; Needleman F; Macphee G; Grosset D
    Mov Disord; 2004 Nov; 19(11):1370-4. PubMed ID: 15389984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggestive evidence for bromocriptine-induced pleurisy.
    Klaassen RJ; Troost RJ; Verhoeven GT; Krepel HP; van der Lely AJ
    Neth J Med; 1996 Jun; 48(6):232-6. PubMed ID: 8710045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson's disease.
    Townsend M; MacIver DH
    Heart; 2004 Aug; 90(8):e47. PubMed ID: 15253989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bromocriptine and pulmonary responses].
    Kinnunen E; Viljanen A
    Duodecim; 1989; 105(19):1614-7. PubMed ID: 2806146
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease.
    Lancet; 1981 Jan; 1(8210):44-5. PubMed ID: 6109080
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromocriptine and pleuropulmonary disease.
    Melmed S; Braunstein GD
    Arch Intern Med; 1989 Feb; 149(2):258-9. PubMed ID: 2916870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.